AAAAAA

   
Results: 1-12 |
Results: 12

Authors: Rijnberk, A Kooistra, HS van Vonderen, IK Mol, JA Voorhout, G van Sluijs, FJ Ijzer, J van den Ingh, TSGAM Boer, P Boer, WH
Citation: A. Rijnberk et al., Aldosteronoma in a dog with polyuria as the leading symptom, DOM ANIM EN, 20(3), 2001, pp. 227-240

Authors: Boer, P Brosh, S Wasserman, L Hammel, I Zoref-Shani, E Sperling, O
Citation: P. Boer et al., Decelerated rate of dendrite outgrowth from dopaminergic neurons in primary cultures from brains of hypoxanthine phosphoribosyltransferase-deficient knockout mice, NEUROSCI L, 303(1), 2001, pp. 45-48

Authors: Rijnberk, A Voorhout, G Kooistra, HS van der Waarden, RJM van Sluijs, FJ IJzer, J Boer, P Boer, WH
Citation: A. Rijnberk et al., Hyperaldosteronism in a cat with metastasised adrenocortical tumour, VET Q, 23(1), 2001, pp. 38-43

Authors: Dijkhorst-Oei, LT Boer, P Rabelink, TJ Koomans, HA
Citation: Lt. Dijkhorst-oei et al., Nitric oxide synthesis inhibition does not impair water immersion-induced renal vasodilation in humans, J AM S NEPH, 11(7), 2000, pp. 1293-1302

Authors: Barton, M Vos, I Shaw, S Boer, P D'uscio, LV Grone, HJ Rabelink, TJ Lattmann, T Moreau, P Luscher, TF
Citation: M. Barton et al., Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: Mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis, J AM S NEPH, 11(5), 2000, pp. 835-846

Authors: Brosh, S Boer, P Sperling, O Zoref-Shani, E
Citation: S. Brosh et al., Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice, J MOL NEURO, 14(1-2), 2000, pp. 87-91

Authors: Schrama, YC Joles, JA van Tol, A Boer, P Koomans, HA Hene, RJ
Citation: Yc. Schrama et al., Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients, TRANSPLANT, 69(3), 2000, pp. 376-383

Authors: Verhagen, AMG Hohbach, J Joles, JA Braam, B Boer, P Koomans, HA Grone, HJ
Citation: Amg. Verhagen et al., Unchanged cardiac angiotensin II levels accompany losartan-sensitive cardiac injury due to nitric oxide synthase inhibition, EUR J PHARM, 400(2-3), 2000, pp. 239-247

Authors: Stroes, ESG van Faassen, EE Yo, M Martasek, P Boer, P Govers, R Rabelink, TJ
Citation: Esg. Stroes et al., Folic acid reverts dysfunction of endothelial nitric oxide synthase, CIRCUL RES, 86(11), 2000, pp. 1129-1134

Authors: Wever, R Boer, P Hijmering, M Stroes, E Verhaar, M Kastelein, J Versluis, K Lagerwerf, F van Rijn, H Koomans, H Rabelink, T
Citation: R. Wever et al., Nitric oxide production is reduced in patients with chronic renal failure, ART THROM V, 19(5), 1999, pp. 1168-1172

Authors: Turkstra, E Boer, P Braam, B Koomans, HA
Citation: E. Turkstra et al., Increased availability of nitric oxide leads to enhanced nitric oxide dependency of tubuloglomerular feedback in the contralateral kidney of rats with2-kidney, 1-clip Goldblatt hypertension, HYPERTENSIO, 34(4), 1999, pp. 679-684

Authors: Verhagen, AMG Braam, B Boer, P Grone, HJ Koomans, HA Joles, JA
Citation: Amg. Verhagen et al., Losartan-sensitive renal damage caused by chronic NOS inhibition does not involve increased renal angiotensin II concentrations, KIDNEY INT, 56(1), 1999, pp. 222-231
Risultati: 1-12 |